Correlation Between China SXT and Lifecore Biomedical

Can any of the company-specific risk be diversified away by investing in both China SXT and Lifecore Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China SXT and Lifecore Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between China SXT Pharmaceuticals and Lifecore Biomedical, you can compare the effects of market volatilities on China SXT and Lifecore Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China SXT with a short position of Lifecore Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of China SXT and Lifecore Biomedical.

Diversification Opportunities for China SXT and Lifecore Biomedical

-0.26

Correlation Coefficient

China SXT  Lifecore Biomedical

Very good diversification

The 3 months correlation between China and Lifecore is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding China SXT Pharmaceuticals and Lifecore Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lifecore Biomedical and China SXT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China SXT Pharmaceuticals are associated (or correlated) with Lifecore Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lifecore Biomedical has no effect on the direction of China SXT i.e., China SXT and Lifecore Biomedical go up and down completely randomly.

Pair Corralation between China SXT and Lifecore Biomedical

Given the investment horizon of 90 days China SXT Pharmaceuticals is expected to generate 5.14 times more return on investment than Lifecore Biomedical. However, China SXT is 5.14 times more volatile than Lifecore Biomedical. It trades about 0.04 of its potential returns per unit of risk. Lifecore Biomedical is currently generating about -0.01 per unit of risk. If you would invest  352.00  in China SXT Pharmaceuticals on December 30, 2024 and sell it today you would lose (77.00) from holding China SXT Pharmaceuticals or give up 21.87% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

China SXT Pharmaceuticals  vs.  Lifecore Biomedical

China SXT Pharmaceuticals

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in China SXT Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, China SXT exhibited solid returns over the last few months and may actually be approaching a breakup point.

Lifecore Biomedical

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lifecore Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Lifecore Biomedical is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with China SXT and Lifecore Biomedical

The main advantage of trading using opposite China SXT and Lifecore Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China SXT position performs unexpectedly, Lifecore Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifecore Biomedical will offset losses from the drop in Lifecore Biomedical's long position.

The idea behind China SXT Pharmaceuticals and Lifecore Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.